Kirk Falconer
Sagard's healthcare royalty platform, launched last year, sees opportunity in the small and mid-sized end of the global market.
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@peimedia.com.